[Preliminary evaluation of the commercial kit Chagas ( Trypanosoma cruzi ) IgG-ELISA ® in Colombian individuals].

Mónica LlanoPaula PavíaAstrid Carolina FlórezAdriana CuéllarJohn Mario GonzálezConcepción J. Puerta2026-03-222026-03-22201510.1590/s0120-41572014000200009https://doi.org/10.1590/s0120-41572014000200009https://andeanlibrary.org/handle/123456789/50431Citaciones: 7The commercial ELISA test allowed us to discriminate the chagasic patients from the controls. A phase II study of diagnostic tests for determining field reliability of this test is required.enChagas diseaseAsymptomaticMedicineTrypanosoma cruziVisceral leishmaniasisSerologyInternal medicineAsymptomatic carrierEpidemiologyLeishmaniasis[Preliminary evaluation of the commercial kit Chagas ( Trypanosoma cruzi ) IgG-ELISA ® in Colombian individuals].article